Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Talbot

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Science Translational Medicine|November 9, 2022
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapiesDaniel B Goodman, Camillia S Azimi, Kendall Kearns, et al.
Blood|December 14, 2023
Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case seriesNathalie Forgeard, Dikélélé Elessa, Alexander Carpinteiro, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2025
Retreatment With Anti-CD38-Based Combinations in Multiple Myeloma in Real-Life: Results From the Emmy Cohort StudyAlexis Talbot, Cyrille Hulin, Aurore Perrot, et al.
American Journal of Hematology|August 10, 2019
Lower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case seriesJean-Simon Rech, Bertrand Arnulf, Constance de Margerie-Mellon, et al.
Haematologica|August 16, 2023
Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life studyPierre-Edouard Debureaux, Nathalie Forgeard, Dikelele Elessa, et al.
Experimental Hematology|July 31, 2012
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemiaAnna Kreutzman, Taina Jaatinen, Dario Greco, et al.
Haematologica|September 20, 2015
Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO)Laurence Simon, Aikaterini Fitsiori, Richard Lemal, et al.
Nature Immunology|September 22, 2022
NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemiaMatthew T Witkowski, Soobeom Lee, Eric Wang, et al.
Nature Biotechnology|October 21, 2025
Integrated epigenetic and genetic programming of primary human T cellsLaine Goudy, Alvin Ha, Ashir A Borah, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor functionVincent Allain, Allison G Rothrock, Pierre-Louis Bernard, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Science Translational Medicine|November 9, 2022
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapiesDaniel B Goodman, Camillia S Azimi, Kendall Kearns, et al.
Blood|December 14, 2023
Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case seriesNathalie Forgeard, Dikélélé Elessa, Alexander Carpinteiro, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2025
Retreatment With Anti-CD38-Based Combinations in Multiple Myeloma in Real-Life: Results From the Emmy Cohort StudyAlexis Talbot, Cyrille Hulin, Aurore Perrot, et al.
American Journal of Hematology|August 10, 2019
Lower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case seriesJean-Simon Rech, Bertrand Arnulf, Constance de Margerie-Mellon, et al.
Haematologica|August 16, 2023
Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life studyPierre-Edouard Debureaux, Nathalie Forgeard, Dikelele Elessa, et al.
Experimental Hematology|July 31, 2012
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemiaAnna Kreutzman, Taina Jaatinen, Dario Greco, et al.
Haematologica|September 20, 2015
Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO)Laurence Simon, Aikaterini Fitsiori, Richard Lemal, et al.
Nature Immunology|September 22, 2022
NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemiaMatthew T Witkowski, Soobeom Lee, Eric Wang, et al.
Nature Biotechnology|October 21, 2025
Integrated epigenetic and genetic programming of primary human T cellsLaine Goudy, Alvin Ha, Ashir A Borah, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor functionVincent Allain, Allison G Rothrock, Pierre-Louis Bernard, et al.
Pageof 7